<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have identified a novel fusion partner of MLL, namely the mastermind like 2 (MAML2 gene), in secondary <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with inv(11)(q21q23) </plain></SENT>
<SENT sid="1" pm="."><plain>RT-PCR and sequencing revealed that exon 7 of MLL was fused to exon 2 of MAML2 in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>The inv(11)(q21q23) results in the creation of a chimeric <z:chebi fb="40" ids="33697">RNA</z:chebi> encoding a putative fusion protein containing 1,408 amino acids from the <z:chebi fb="0" ids="29318,29339">NH2</z:chebi>-terminal part of MLL and 952 amino acids from the COOH-terminal part of MAML2 </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="0" ids="29318,29339">NH2</z:chebi>-terminal part of MAML2, a basic domain including a binding site of the intracellular domain of NOTCH, was deleted in MLL-MAML2 </plain></SENT>
<SENT sid="4" pm="."><plain>MLL-MAML2 in <z:e sem="disease" ids="C0280449" disease_type="Neoplastic Process" abbrv="">secondary AML</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and MECT1-MAML2 in mucoepithelioid <z:mp ids='MP_0002038'>carcinoma</z:mp>, benign Wartin's <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, and <z:mpath ids='MPATH_224'>clear cell hidradenoma</z:mpath> consist of the same COOH-terminal part of MAML2 </plain></SENT>
<SENT sid="5" pm="."><plain>A luciferase assay revealed that MLL-MAML2 suppressed HES1 promoter activation by the NOTCH1 intracellular domain </plain></SENT>
<SENT sid="6" pm="."><plain>MAML2 involving a chimeric gene might contribute to <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in multiple <z:hpo ids='HP_0002664'>neoplasms</z:hpo> by the disruption of NOTCH signaling </plain></SENT>
</text></document>